D2/3 Agonist during Learning Potentiates Cued Risky Choice
Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gamb...
Saved in:
Published in | The Journal of neuroscience Vol. 43; no. 6; pp. 979 - 992 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Baltimore
Society for Neuroscience
08.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues. |
---|---|
AbstractList | Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues. Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos + neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues. SIGNIFICANCE STATEMENT D 2/3 receptor agonists, used to treat Parkinson's disease, can cause gambling disorder through an unknown mechanism. Ropinirole increased risky decision-making in rats, but only when wins were paired with casino-inspired sounds and lights. This was mediated by increased win-stay behavior after large unlikely wins early in learning, indicating enhanced model-free learning. cFos imaging showed that ropinirole suppressed activity of midbrain dopamine neurons, an effect that was mimicked by the addition of win-paired cues. The degree of risky choice rats exhibited was uniquely predicted by the ratio of midbrain dopamine:PFC activity. Depriving the PFC of the endogenous dopaminergic teaching signal may therefore drive risky decision-making on-task, and ropinirole acts synergistically with win-paired cues to amplify this. Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues.SIGNIFICANCE STATEMENT D2/3 receptor agonists, used to treat Parkinson's disease, can cause gambling disorder through an unknown mechanism. Ropinirole increased risky decision-making in rats, but only when wins were paired with casino-inspired sounds and lights. This was mediated by increased win-stay behavior after large unlikely wins early in learning, indicating enhanced model-free learning. cFos imaging showed that ropinirole suppressed activity of midbrain dopamine neurons, an effect that was mimicked by the addition of win-paired cues. The degree of risky choice rats exhibited was uniquely predicted by the ratio of midbrain dopamine:PFC activity. Depriving the PFC of the endogenous dopaminergic teaching signal may therefore drive risky decision-making on-task, and ropinirole acts synergistically with win-paired cues to amplify this.Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and neurobiological mechanisms underlying these adverse effects are unknown. Recent data show that adding win-paired sound and light cues to the rat gambling task (rGT) potentiates risky decision-making and impulsivity via the dopamine system, and that changing dopaminergic tone has a greater influence on behavior while subjects are learning task contingencies. Dopamine agonist therapy may therefore be potentiating risk-taking by amplifying the behavioral impact of gambling-related cues on novel behavior. Here, we show that ropinirole treatment in male rats transiently increased motor impulsivity but robustly and progressively increased choice of the high-risk/high-reward options when administered during acquisition of the cued but not uncued rGT. Early in training, ropinirole increased win-stay behavior after large unlikely wins on the cued rGT, indicative of enhanced model-free learning, which mediated the drug's effect on later risk preference. Ex vivo cFos imaging showed that both chronic ropinirole and the addition of win-paired cues suppressed the activity of dopaminergic midbrain neurons. The ratio of midbrain:prefrontal cFos+ neurons was lower in animals with suboptimal choice patterns and tended to predict risk preference across all rats. Network analyses further suggested that ropinirole induced decoupling of the dopaminergic cells of the VTA and nucleus accumbens but only when win-paired cues were present. Frontostriatal activity uninformed by the endogenous dopaminergic teaching signal therefore appeared to perpetuate risky choice, and ropinirole exaggerated this disconnect in synergy with reward-paired cues.SIGNIFICANCE STATEMENT D2/3 receptor agonists, used to treat Parkinson's disease, can cause gambling disorder through an unknown mechanism. Ropinirole increased risky decision-making in rats, but only when wins were paired with casino-inspired sounds and lights. This was mediated by increased win-stay behavior after large unlikely wins early in learning, indicating enhanced model-free learning. cFos imaging showed that ropinirole suppressed activity of midbrain dopamine neurons, an effect that was mimicked by the addition of win-paired cues. The degree of risky choice rats exhibited was uniquely predicted by the ratio of midbrain dopamine:PFC activity. Depriving the PFC of the endogenous dopaminergic teaching signal may therefore drive risky decision-making on-task, and ropinirole acts synergistically with win-paired cues to amplify this. |
Author | Chernoff, Chloe S Ramaiah, Shrishti Kaur, Sukhbir Russell, Brittney Winstanley, Catharine A Mortazavi, Leili Brodie, Hannah G Hathaway, Brett A Hynes, Tristan J |
Author_xml | – sequence: 1 givenname: Leili surname: Mortazavi fullname: Mortazavi, Leili – sequence: 2 givenname: Tristan surname: Hynes middlename: J fullname: Hynes, Tristan J – sequence: 3 givenname: Chloe surname: Chernoff middlename: S fullname: Chernoff, Chloe S – sequence: 4 givenname: Shrishti surname: Ramaiah fullname: Ramaiah, Shrishti – sequence: 5 givenname: Hannah surname: Brodie middlename: G fullname: Brodie, Hannah G – sequence: 6 givenname: Brittney surname: Russell fullname: Russell, Brittney – sequence: 7 givenname: Brett surname: Hathaway middlename: A fullname: Hathaway, Brett A – sequence: 8 givenname: Sukhbir surname: Kaur fullname: Kaur, Sukhbir – sequence: 9 givenname: Catharine surname: Winstanley middlename: A fullname: Winstanley, Catharine A |
BookMark | eNpdj8tOwzAQRS1URB_wCygSGzZpx4_EDgukKhQoqigqdB3ZidO6pHaJE6T-PUGwgdXM6B4dzR2innVWI3SJYYwjQidPz7P1avmazseYRUlIyJgAISdo0KXdyQD30AAIhzBmnPXR0PsdAHDA_Az1aRwTKng8QDd3ZEKD6cZZ45ugaGtjN8FCy9p-Ly-u0bYxstE-SFtdBCvj349BunUm1-fotJSV1xe_c4TW97O39DFcLB_m6XQRHgjHTVjmmjEQuVCYERGXPJe4gDgCThJRRkxJqogqCipAFUmpIqWkiCgkhNGISUVH6PbHe2jVXhd591Etq-xQm72sj5mTJvubWLPNNu4zSxIQFItOcP0rqN1Hq32T7Y3PdVVJq13rM8JjSinDmHXo1T9059radvU6iscEIAFKvwA603JK |
ContentType | Journal Article |
Copyright | Copyright Society for Neuroscience Feb 8, 2023 Copyright © 2023 the authors. Copyright © 2023 the authors 2023 |
Copyright_xml | – notice: Copyright Society for Neuroscience Feb 8, 2023 – notice: Copyright © 2023 the authors. – notice: Copyright © 2023 the authors 2023 |
DBID | 7QG 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
DOI | 10.1523/JNEUROSCI.1459-22.2022 |
DatabaseName | Animal Behavior Abstracts Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts Animal Behavior Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1529-2401 |
EndPage | 992 |
ExternalDocumentID | PMC9908318 |
GrantInformation_xml | – fundername: Stanford Department of Psychology – fundername: ; grantid: CGS-M – fundername: Canadian Institute for Health Research (CIHR) grantid: PJT-162312; FBD-170900 |
GroupedDBID | --- -DZ -~X .55 18M 2WC 34G 39C 53G 5GY 5RE 5VS 7QG 7QR 7TK 7U7 7U9 8FD AAFWJ AAJMC ABBAR ABIVO ACGUR ACNCT ADBBV ADHGD AENEX AFCFT AFOSN AFSQR AHWXS ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1K CS3 DIK DU5 E3Z EBS EJD F5P FR3 GX1 H13 H94 HYE H~9 KQ8 L7B OK1 P0W P2P P64 QZG R.V RHI RPM TFN TR2 W8F WH7 WOQ X7M YBU YHG YKV YNH YSK 7X8 5PM |
ID | FETCH-LOGICAL-p271t-fce4408c8b14286f7ca1d06507298f54ba3b2bdd380bd9fb5bba8530924354ab3 |
ISSN | 0270-6474 1529-2401 |
IngestDate | Thu Aug 21 18:41:55 EDT 2025 Sun Aug 24 03:39:24 EDT 2025 Mon Jun 30 16:42:30 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | SfN exclusive license. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p271t-fce4408c8b14286f7ca1d06507298f54ba3b2bdd380bd9fb5bba8530924354ab3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author contributions: L.M. and C.A.W. designed research; L.M., T.J.H., C.S.C., S.R., H.G.B., B.R., B.A.H. and S.K. performed research; L.M. analyzed data; L.M. wrote the first draft of the paper; L.M. and C.A.W. edited the paper; L.M. and C.A.W. wrote the paper. |
ORCID | 0000-0002-1905-2199 0000-0001-9838-4935 0000-0001-7032-4471 |
PMID | 36623876 |
PQID | 2776200903 |
PQPubID | 2049535 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9908318 proquest_miscellaneous_2763334114 proquest_journals_2776200903 |
PublicationCentury | 2000 |
PublicationDate | 20230208 |
PublicationDateYYYYMMDD | 2023-02-08 |
PublicationDate_xml | – month: 02 year: 2023 text: 20230208 day: 08 |
PublicationDecade | 2020 |
PublicationPlace | Baltimore |
PublicationPlace_xml | – name: Baltimore |
PublicationTitle | The Journal of neuroscience |
PublicationYear | 2023 |
Publisher | Society for Neuroscience |
Publisher_xml | – name: Society for Neuroscience |
SSID | ssj0007017 |
Score | 2.4661293 |
Snippet | Impulse control and/or gambling disorders can be triggered by dopamine agonist therapies used to treat Parkinson's disease, but the cognitive and... |
SourceID | pubmedcentral proquest |
SourceType | Open Access Repository Aggregation Database |
StartPage | 979 |
SubjectTerms | Agonists Choice learning Cognitive ability Cognitive tasks Decision making Decoupling Dopamine Dopamine D2 receptors Gambling Impulsive behavior Impulsivity Learning Mental task performance Mesencephalon Movement disorders Neurodegenerative diseases Neurons Nucleus accumbens Parkinson's disease Risk Risk taking |
Title | D2/3 Agonist during Learning Potentiates Cued Risky Choice |
URI | https://www.proquest.com/docview/2776200903 https://www.proquest.com/docview/2763334114 https://pubmed.ncbi.nlm.nih.gov/PMC9908318 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkNBe0GAgygYyEuKlSpfGufJWZaAxWDXWTtpbZTcOjViTakuRtt_Cj-Uc27mNPcBeoirOrTlfjj_b53yHkPcpSxI38VLLdhNmgZcMrTBNIouLwPc94TlBgInCJxP_6Nw9vvAuer3frailTSmGi9t780oeYlXYB3bFLNn_sGx9UdgBv8G-sAULw_afbHyIsqZsMP5RoP5tlXL4rZrtOC1KjAVCNjmIN8Asz7Lrn6hmXJiAt4qVNvlhipm2NC6byFik6bf8l06mltllVgPixqj9z9BfYDbUsIkZkFd5oXUf4-VlIQfTuu2Mr3jG1aTOFAUOlmXWnoFwmApaDpsZyFZ46eTuA2pP5gQwRnV1OZ6hNJ7WUUs7o7Yr1opNBnJtvxrpijOmi450-by_vL-nVCiOJxgEOY2_QC_gwT0w3c7pnABWXK8UJpgP9C8M7ohxq-799CSGnjoEn_eIPAbIOlgf4-v3Ros-sFU95_rPmfxzeIiD-x9hmzyp7tcZz3SjcVv0ZrZDnhrr07EG2TPSk_lzsjvOeVmsbugHqiKF1RLMLvl46BwwalBHNepohTraQh1F1FGFOqpR94Kcf_40i48sU4PDWjvBqLTShcSa5IsQJwtDPw0WfJQgrYdBWZh6ruBMOCJJWGiLJEqFJwQHBmjDsJ55LhfsJdnKi1y-IpTDgcDXZWoDiZc-XFKwSOL6krvggIQ-2a_eydx8ZNdzePE-LuDZrE_e1c3gAnFdi-ey2OAxPmPAxkZunwSddzlfa8mWOYqod1vybKnE1I2NXz_4zD2y3XwU-2SrvNrIN0BUS_FW4eUPZA-TyQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=D2%2F3+Agonist+during+Learning+Potentiates+Cued+Risky+Choice&rft.jtitle=The+Journal+of+neuroscience&rft.au=Mortazavi%2C+Leili&rft.au=Hynes%2C+Tristan+J.&rft.au=Chernoff%2C+Chloe+S.&rft.au=Ramaiah%2C+Shrishti&rft.date=2023-02-08&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=43&rft.issue=6&rft.spage=979&rft.epage=992&rft_id=info:doi/10.1523%2FJNEUROSCI.1459-22.2022&rft_id=info%3Apmid%2F36623876&rft.externalDocID=PMC9908318 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon |